ArticlePloS one2021

Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.

Naoki Takada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.